Skip to the page

Data / Form D filings / Belenos Biosciences, Inc.

Belenos Biosciences, Inc.: Form D filing

Belenos Biosciences, Inc., a company in New York, NY, filed a Form D with the SEC in 2024. The latest, on July 17, 2024, reports $48 million sold of a $55 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
601 LEXINGTON AVENUE, 54TH FLOOR, New York, NY, 10022
Phone
(212) 739-6400
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2030450

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 17, 2024New notice$55,000,000$48,000,000$7,000,0002Jul 8, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Bo Donnie ChenDirector
Carl Donnie GordonDirector
Tania Donnie DimitrovaExecutive Officer
David Donnie WangDirector
Megan Donnie DowExecutive Officer
StJohn Donnie McGrathExecutive Officer, Director

Other companies in New York that filed recently

Every Form D from the week of Jul 15, 2024 · All recent filings in New York · All recent Other filings

Read from SEC EDGAR. Amount sold is what Belenos Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.